Kevin Hern Dumped 7 Stocks in One Day. Here's the Tape.

The Oklahoma Republican sold everything from Comcast to Diageo on August 5. His broader trading record is 31-for-74. Ways and Means oversees health. He trades health stocks.

By Beltway Alpha · Edited by Sean Baptiste · Published 2026-08-12

Kevin Hern is trending on Google News today, and the most interesting thing about that fact is that there's no particular reason for it, no floor drama, no committee spectacle, no quote that went viral. What there is, sitting quietly in the public disclosure system, is a single trading day in early August where Hern filed seven separate stock sales, all on the same date, spanning media, spirits, consumer staples, pharma, and a small-cap media spinoff most people have never heard of. Seven tickers. One day. The filings are public. The interpretation is yours.

The August 5 Sweep

On August 5, 2026, Kevin Hern filed seven stock sales with the House disclosure system, all in the $1,001–$15,000 range. The names on the list:

Comcast (CMCSA), the cable and media giant currently navigating a slow-motion cord-cutting reckoning
Diageo (DEO), the British spirits conglomerate behind Johnnie Walker, Guinness, and roughly a third of your bar cart
Estée Lauder (EL), the luxury beauty company that has spent two years getting crushed by a Chinese market slowdown
Kenvue (KVUE), the J&J consumer health spinoff that makes Tylenol and Band-Aid and has traded sideways since its 2023 IPO
Mondelez International (MDLZ), the snack conglomerate behind Oreo and Cadbury, whose margins have been getting squeezed by cocoa prices
Organon & Co. (OGN), the women's health pharma spinoff from Merck, which has traded at a steep discount to book value for most of its existence
Versant Media Group (VSNT), a small-cap media company that most professional investors couldn't place without a Bloomberg terminal

Every single one of those is a sale. Not a purchase. Not a mix. Seven sells, filed together, same date.

The individual amounts are small, the $1,001–$15,000 disclosure band is the lowest bracket in the House system, meaning each sale could have netted him $1,001 or $14,999 and we'd never know which. But the breadth of the liquidation is the thing. This is not trimming a position. This looks like clearing a shelf.

His Broader Record: 31 for 74

Here's the thing about Kevin Hern's trading record over the full scored sample: it's not good.

Across 74 trades with measurable 30-day alpha data, Hern has come out ahead of the S&P 500 on 31 of them. That's a 41.9% hit rate. The mean 30-day alpha across the whole portfolio is negative 1.0%. Which means, on average, when Hern trades, the position underperforms the index over the following month.

The worst single trade in the record: a sale of BNP Paribas ADR (BNPQY) on October 9, 2025, in the $1 million–$5 million range, that underperformed the market by 14.1 percentage points over the next 30 days. There's a second BNPQY sale filed the same day in the $250,000–$500,000 range, with the identical negative alpha. A sale of Progress Software (PRGS) in March 2026, in the $50,000–$100,000 range, posted negative 20.3% alpha over 30 days, the worst single-trade outcome in the scored set.

The best trades in the record carry a different kind of weight. More on that in a moment.

Ways and Means. Health Subcommittee. Healthcare Stocks.

Hern sits on the House Committee on Ways and Means, including the Health subcommittee and the Tax subcommittee. Ways and Means has jurisdiction over Medicare, Medicaid, and broad health financing policy. That's the committee that decides how much the federal government pays for drugs and procedures and insurance premiums.

With that in mind, here are the committee-overlap trades in the scored record, the ones where the ticker sits inside the actual remit of Hern's committee assignments:

UnitedHealth Group (UNH), purchased June 25, 2024, $1,001–$15,000. Thirty-day alpha: +12.8%. Committee overlap: Healthcare.
Chubb (CB), purchased July 8, 2024, $1,001–$15,000. Thirty-day alpha: +13.3%. Committee overlap: Insurance.
Johnson & Johnson (JNJ), purchased March 5, 2024, $1,001–$15,000. Thirty-day alpha: -0.2%. Committee overlap: Pharmaceuticals.
Boston Scientific (BSX), sold October 28, 2025, $15,000–$50,000. Thirty-day alpha: -0.4%. Committee overlap: Healthcare.
UnitedHealth Group (UNH), sold December 23, 2025, $250,000–$500,000. Thirty-day alpha: +2.0%. Committee overlap: Healthcare.

Two of the five committee-overlap trades posted double-digit positive alpha in the 30 days that followed. Two were roughly flat. One, the large UNH sale, posted modest positive alpha.

The alpha data doesn't tell us why those outcomes happened. Markets are noisy. Thirty days is a short window. And the broader record, 31-for-74 overall, argues against any narrative of consistent outperformance. But the committee-overlap trades are the ones that carry the oversight angle, per the actual remit of Ways and Means. The reader can decide what to make of the pairing.

The Voting Record: July 2026

Hern's vote history over the past 90 days runs through the NDAA and a pair of financial-access bills. The market-relevant ones:

On July 21, he voted Yea on the Main Street Capital Access Act (H.R. 6955), which passed. On July 14, he voted Yea on the Protecting Privacy in Purchases Act (H.R. 1181), which also passed. Neither bill sits squarely in Ways and Means jurisdiction in a way that creates a clean COI angle, and the trade filings don't overlap with either vote date.

The NDAA votes are worth cataloging because they show what a busy July on the floor looks like. Hern voted Yea on the final NDAA passage (H.R. 8800) on July 22. He voted Yea on an amendment codifying chaplain protections, Yea on an amendment banning automated speed cameras on military installations, Yea on an amendment requiring a report on reducing the Pentagon civilian workforce by 200,000 (that one failed), and Nay on a Lauren Boebert amendment that would have preserved a cap on athletes receiving alternative service obligations. The Boebert amendment failed.

None of those votes intersect with Ways and Means jurisdiction. None overlap with the August 5 trade filings in timing. No overlap in this record means no overlap, that's the full picture.

The August 5 Portfolio, Contextualized

Step back for a second and look at what Hern sold on August 5 as a coherent set. Comcast is a regulated cable and broadband company facing both FCC oversight and competitive pressure from streaming. Diageo is an alcohol company with exposure to trade tariffs and excise taxes, both policy-sensitive categories. Estée Lauder is a luxury consumer company with China exposure. Kenvue makes consumer health products including OTC drugs. Mondelez has commodity price risk. Organon is a pharmaceutical spinoff. Versant Media is a small media company.

The through-line, if there's one, is that several of these companies sit in sectors with active legislative and regulatory exposure right now. That could mean something. It could also mean Hern's financial advisor had a bad week and decided to rebalance. The filing doesn't say. The filing never says.

Members are required to disclose. They are not required to divest, recuse, abstain, or explain themselves. That's the rule. Yes, really.

The Full Picture

Hern's 90-day trade window, seven sales, all filed on the same date, sits on top of a longer record that looks like this: 74 scored trades, 31 positive outcomes versus the S&P 500, a mean 30-day alpha of negative one percent. The portfolio-wide record is not the profile of someone running a hot hand.

The committee-overlap trades are a smaller, more specific subset. Hern sits on the Ways and Means Health subcommittee. He has traded UnitedHealth Group twice, once as a buy that posted +12.8% alpha, once as a sale at $250,000–$500,000 that posted +2.0% alpha. He purchased Chubb, which falls in the insurance space Ways and Means touches, and that trade posted +13.3% alpha. He purchased Johnson & Johnson in the pharmaceutical space and that one was essentially flat.

That's five committee-overlap trades in the scored record. Three of them made money relative to the market. Two were flat to slightly negative. It's a small sample. The math is what it is.

Hern is trending. His full disclosure record is public. His committee assignments are public. His votes are public. His trade dates are public. The August 5 sales are public.

The receipts are public. Make of them what you make of them.

Blind Trust — Congress trades. We keep the box score.

Blind Trust tracks every public stock-trade disclosure filed by a member of the United States Congress under the STOCK Act of 2012. Each trade is scored on a 0–100 Heat Index, flagged when its timing overlaps a committee vote or sector-moving news event, and surfaced in a daily editorial digest under the Beltway Alpha byline.

Every receipt on this site links to a public filing. We don't have anonymous sources. We don't write "sources tell us." If a chart can't be pointed at — a Periodic Transaction Report, a roll-call vote, a committee roster, a published poll — we don't make the claim.

What you can do here

News desk — daily editorial pieces on the highest-scoring trades, vote-trade overlaps, and STOCK Act enforcement gaps. Articles cite the underlying filings by hyperlink.
Power Rankings — every current House and Senate member, ranked by trade win rate, average alpha, and Heat Index counts over the trailing 12 months.
Roll-call votes — 119th Congress vote record overlaid with stock-trade activity around each vote.
STOCK Act late filers — disclosures filed past the 45-day window mandated by the STOCK Act, ranked by gap length and frequency.
Supreme Court justices — annual financial disclosures for the nine sitting US Supreme Court justices.
Fantasy Congress — free fantasy-sports game where you draft a roster of US Congress members and score on their real public STOCK Act disclosures. No real-money wagers.

How the Heat Index works

The Heat Index combines five inputs: (1) the 30-day forward alpha of the traded ticker versus the S&P 500, (2) the politician's committee-jurisdiction overlap with the company's sector, (3) the recency of a relevant roll-call vote, (4) the size of the disclosed trade range, and (5) the gap between trade date and disclosure date. Blazing trades score 70+. Warm trades score 40–69. Cold trades score below 40. Full scoring methodology →

Editorial standards

Blind Trust is a free, ad-supported publication. We do not solicit, accept, or publish paid placements. Articles are drafted with AI tooling against the Beltway Alpha voice guide and verified against our database of trades, votes, polls, and committee assignments before publish. Every error gets a public correction. Editorial standards · Corrections · Methodology

Publisher

Blind Trust is published by DreamKey. Editorial and tip line: support@blindtrust.io. Read about the publisher or about the Beltway Alpha byline.

Blind Trust · Editorial

Kevin Hern Dumped 7 Stocks in One Day. Here's the Tape.

The Oklahoma Republican sold everything from Comcast to Diageo on August 5. His broader trading record is 31-for-74. Ways and Means oversees health. He trades health stocks.